LOADING
Comparing Merck & Company (MRK) and Qualcomm Inc (QCOM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | QCOM |
|---|---|---|
| Price | $113.41 | $200.08 |
| Change Today | -0.04% | -6.14% |
| Market Cap | $280.2B | $224.7B |
| P/E Ratio | 32.0 | 22.6 |
| Forward P/E | 22.0 | 20.6 |
| PEG Ratio | 5.18 | 0.94 |
| EPS | $3.55 | $9.42 |
| Revenue Growth (YoY) | 4.9% | -3.5% |
| Profit Margin | 13.6% | 22.3% |
| Return on Equity | 18.9% | 36.1% |
| Dividend Yield | 2.92% | 1.69% |
| Beta | 0.20 | 1.49 |
| 52-Week High | $124.22 | $247.90 |
| 52-Week Low | $71.76 | $121.99 |
| Volume | 5.3M | 24.9M |
Merck & Company is the larger company by market capitalization. Qualcomm Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Qualcomm Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.